Mallinckrodt to Present at Morgan Stanley 2014 Global Healthcare Conference

Morgan Stanley Global Healthcare Conference 2014

DUBLIN--()--Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, will present at the Morgan Stanley Global Healthcare Conference in New York on Monday, September 8, 2014. Mark Trudeau, President and Chief Executive Officer of Mallinckrodt, will represent the company in a session scheduled to begin at 9:20 AM, Eastern Time.

Individuals who are unable to attend the meeting can access a replay through the following link: http://www.mallinckrodt.com/investor_relations

ABOUT MALLINCKRODT:

Mallinckrodt is a global specialty pharmaceutical and medical imaging business that develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. Areas of focus include analgesics and CNS drugs for prescribing by office- and hospital-based physicians, and autoimmune and rare disease specialty areas like neurology, rheumatology, nephrology and pulmonology. The company's core strengths include the acquisition and management of highly regulated raw materials; deep regulatory expertise; and specialized chemistry, formulation and manufacturing capabilities. The company's Specialty Pharmaceuticals segment includes branded and specialty generic drugs and active pharmaceutical ingredients, and the Global Medical Imaging segment includes contrast media and nuclear imaging agents. Mallinckrodt has more than 5,500 employees worldwide and a commercial presence in roughly 65 countries. The company's fiscal 2013 revenue totaled $2.2 billion. To learn more about Mallinckrodt, visit www.mallinckrodt.com.

Contacts

Mallinckrodt
John Moten, 314-654-6650
Vice President, Investor Relations
john.moten@mallinckrodt.com
or
Lynn Phillips, 314-654-3263
Manager, Communications
lynn.phillips@mallinckrodt.com

Sharing

Contacts

Mallinckrodt
John Moten, 314-654-6650
Vice President, Investor Relations
john.moten@mallinckrodt.com
or
Lynn Phillips, 314-654-3263
Manager, Communications
lynn.phillips@mallinckrodt.com